NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market Tuesday that its third quarter revenues declined 12 percent year over year in the wake of a key customer shifting to a competitor's platform.

The loss of the account, plus the challenges experienced by US customers who offer its pharmacogenomic tests in gaining reimbursement, caused the company to lower its full-year 2013 guidance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.